Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2000
03/09/2000WO2000012514A1 Novel compounds
03/09/2000WO2000012510A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
03/09/2000WO2000012505A2 Triazolopyridazine derivatives for treating anxiety and enhancing cognition
03/09/2000WO2000012502A1 Pyrroloquinolines for treatment of obesity
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012496A1 Novel cdk inhibitors having flavone structure
03/09/2000WO2000012488A1 Pyrazine compounds
03/09/2000WO2000012481A2 Indazole derivatives with 5-ht2 receptor activity________________
03/09/2000WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors
03/09/2000WO2000012475A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000WO2000012467A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
03/09/2000WO2000012462A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/09/2000WO2000012126A1 Autoantibody inhibitors
03/09/2000WO2000012119A2 PHARMACEUTICAL COMPOSITIONS COMPRISING FACTOR XIIIa
03/09/2000WO2000012115A1 Use of composition in the treatment of schizophrenia
03/09/2000WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000012093A1 Method of treating neurodegenerative diseases
03/09/2000WO2000012091A1 Remedies for spinal canal stenosis
03/09/2000WO2000012090A1 THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000WO2000012073A1 Use of 5ht-6 antagonists
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000WO2000011952A1 Compositions and methods for treatment of mitochondrial diseases
03/09/2000WO2000001377A3 Nalmefene in combination with opioid analgesics
03/09/2000WO1999062548A9 Methods and compositions for diagnosing tauopathies
03/09/2000WO1999059524A3 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
03/09/2000WO1999020260A3 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
03/09/2000DE19941675A1 2-Amino-bicyclo[3.1.0] hexan-2,6-dicarbonsäurederivate und ein Verfahren zu deren Herstellung 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivatives and a process for their preparation
03/09/2000DE19840611A1 GABA-uptake-Inhibitoren mit Pyrrolidinstruktur GABA-uptake inhibitors with Pyrrolidinstruktur
03/09/2000CA2696878A1 Compositions and methods for treatment of mitochondrial diseases
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2629396A1 The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
03/09/2000CA2342205A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000CA2341986A1 Pyrroloquinolines for treatment of obesity
03/09/2000CA2341810A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000CA2341612A1 Indazole derivatives with 5-ht2 receptor activity
03/09/2000CA2341543A1 Pyrazine compounds
03/09/2000CA2341525A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/09/2000CA2341499A1 Pharmaceutical compositions comprising factor xiiia
03/09/2000CA2341458A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/09/2000CA2341452A1 Triazolopyridazine derivatives for treating anxiety and enhancing cognition
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2340617A1 Genes associated with neurotransmitter processing
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2339539A1 Modulating multiple lineage kinase proteins
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000CA2339140A1 Method of treating neurodegenerative diseases
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0984012A2 Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
03/08/2000EP0984008A2 Nitrosation process
03/08/2000EP0983995A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds
03/08/2000EP0983994A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds
03/08/2000EP0983766A1 A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt
03/08/2000EP0983380A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
03/08/2000EP0983354A2 Neurotrophic factor receptors
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983293A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/08/2000EP0983268A1 Amidine derivatives as inhibitors of nitric oxide synthase
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983266A1 Compounds
03/08/2000EP0983265A1 Endothelin receptor antagonists
03/08/2000EP0983262A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983245A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
03/08/2000EP0983244A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
03/08/2000EP0983243A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
03/08/2000EP0983222A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983065A1 Gastric-retained pharmaceutical composition
03/08/2000EP0983062A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
03/08/2000EP0835125A4 Cd4-derived peptides that inhibit immune responses
03/08/2000EP0783513A4 Novel estrenes for inducing hypothalamic effects
03/08/2000EP0770082B1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments
03/08/2000EP0656062B1 Dorsal tissue affecting factor and compositions
03/08/2000CN1246868A Melanocortins
03/08/2000CN1246866A Monocyclic compounds with four bifunctional residues having NK-2 antagonist action
03/08/2000CN1246860A 3-aryl substituted pyrazolo [4,3-d] pyrimidine derivatives, corticotropin-releasing factor receptor (CRT1) specific ligands
03/08/2000CN1246859A (4-piperidnyl)-1H-2-benzopyran derivatives useful as antipsychotic agents
03/08/2000CN1246857A Substituted pyrimidinone and pyridinone compounds and their use
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246848A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
03/08/2000CN1246795A Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1246361A Chinese medicine for preventing recurrence of drug taking
03/08/2000CN1246357A Chinese patent medicine for treating epilepsy
03/08/2000CN1050128C 5-acrylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions
03/08/2000CN1050127C Benocycloheptenes and benzoxepines preparing process thereof and pharmaceutical compositions containing them
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/07/2000USRE36607 Pyrrolidine compounds and process of preparing
03/07/2000US6034250 Nitrone compounds
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034117 Administering acetyl choline esterase inhibitor
03/07/2000US6034113 Derivatives of 1,3,4-oxadiazolone
1 ... 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 ... 1833